2384. The Relationship Between Rifaxamin Use and the Prevalence of Clostridiodes difficile and Vancomycin-Resistant Enterococcus in Patients with Advanced Liver Disease

BACKGROUND: Rifaximin (RFX) is a minimally absorbed antibiotic that achieves high concentrations after administration in the gut lumen. Previously, RFX showed activity against Clostridiodes difficile (C. difficile) recurrences post treatment with little overall impact on the normal fecal microbiota....

Descripción completa

Detalles Bibliográficos
Autores principales: Alberto. De Jesus, Francisco, Kuper, Kristi, Haider, Alyzeh, Sackey, Joachim, Finkel, Diana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810353/
http://dx.doi.org/10.1093/ofid/ofz360.2062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810353/
http://dx.doi.org/10.1093/ofid/ofz360.2062

Ejemplares similares